Cancer-induced Hypercoagulability as a marker of prognosis
|II||Observation||Open||18 and over||University of South Manchester|| Eudract No:
Prospective clinical cohort study investigating durtion and significance of hypercoagulable response to surgery, correlated with tumour molecular phenotype and outcome. Pre ans post-operative plasma markers of clotting cascade activation, platelet activation, fibronolytic activity and activation of coagulation will be compared to tissue expression of equivalent markers, development of clinical VTE, tumour clinicopathological prognostic factors, and survival in patients undergoing elective abdominal and breast cancer surgery. Patients undergoing non-cancer surgery (matched for age, sex and type of surgery to the cancer patients) will provide baseline response to surgery.
University of South Manchester
Trial Not Open
0151 794 8974
Sorry there are currently no job vacancies
Some useful downloads: